Overview

Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma

Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if secretin-enhanced CT is a useful noninvasive screening tool for pancreatic cancer in a high-risk population.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
ChiRhoClin, Inc.
Treatments:
Secretin